Nazha, B.; Zhang, C.; Chen, Z.; Ragin, C.; Owonikoko, T.K.
Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER–Medicare Database Analysis. Cancers 2022, 14, 3206.
https://doi.org/10.3390/cancers14133206
AMA Style
Nazha B, Zhang C, Chen Z, Ragin C, Owonikoko TK.
Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER–Medicare Database Analysis. Cancers. 2022; 14(13):3206.
https://doi.org/10.3390/cancers14133206
Chicago/Turabian Style
Nazha, Bassel, Chao Zhang, Zhengjia Chen, Camille Ragin, and Taofeek K. Owonikoko.
2022. "Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER–Medicare Database Analysis" Cancers 14, no. 13: 3206.
https://doi.org/10.3390/cancers14133206
APA Style
Nazha, B., Zhang, C., Chen, Z., Ragin, C., & Owonikoko, T. K.
(2022). Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER–Medicare Database Analysis. Cancers, 14(13), 3206.
https://doi.org/10.3390/cancers14133206